ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,651,845 | +22.7% | 227,030 | +19.0% | 0.91% | +43.4% |
| Q2 2023 | $3,790,997 | +16.0% | 190,790 | 0.0% | 0.63% | +0.6% |
| Q1 2023 | $3,268,233 | -12.5% | 190,790 | 0.0% | 0.63% | -13.1% |
| Q4 2022 | $3,733,760 | -13.6% | 190,790 | -29.5% | 0.72% | -15.0% |
| Q3 2022 | $4,322,000 | +16.0% | 270,790 | 0.0% | 0.85% | +13.3% |
| Q2 2022 | $3,726,000 | -22.7% | 270,790 | -10.9% | 0.75% | -12.3% |
| Q1 2022 | $4,821,000 | -42.3% | 303,975 | -20.6% | 0.86% | -32.0% |
| Q4 2021 | $8,360,000 | -44.7% | 382,975 | -24.3% | 1.26% | 0.0% |
| Q3 2021 | $15,127,000 | -27.4% | 506,085 | +7.6% | 1.26% | -25.3% |
| Q2 2021 | $20,822,000 | +4.8% | 470,135 | +5.0% | 1.68% | +11.8% |
| Q1 2021 | $19,873,000 | -1.4% | 447,885 | +21.9% | 1.51% | +6.1% |
| Q4 2020 | $20,147,000 | +332.8% | 367,385 | +54.9% | 1.42% | +173.1% |
| Q2 2018 | $4,655,000 | +14.9% | 237,158 | +9.7% | 0.52% | +17.1% |
| Q1 2018 | $4,053,000 | – | 216,158 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |